SHA:603229 Market Cap

SHA:603229 has a market cap or net worth of 7.79 billion as of July 16, 2025. Its market cap has increased by 25.16% in one year.

Market Cap

7.79B

Enterprise Value

6.98B

Revenue

801.01M

Ranking

n/a

PE Ratio

36.98

Stock Price

9.37

Market Cap Chart

Since May 9, 2017, SHA:603229's market cap has increased from 1.80B to 7.79B, an increase of 333.02%. That is a compound annual growth rate of 19.59%.

Market Cap History

Date	Market Cap	% Change
Jul 16, 2025	7.79B	-6.03%
Dec 31, 2024	8.29B	5.87%
Dec 29, 2023	7.83B	-18.09%
Dec 30, 2022	9.56B	-8.49%
Dec 31, 2021	10.45B	19.25%
Dec 31, 2020	8.76B	170.38%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jiangsu Hengrui Medicine	381.75B
Shenzhen Mindray Bio-Medical Electronics	260.09B
WuXi AppTec	225.38B
Sichuan Biokin Pharmaceutical	119.10B
Zhangzhou Pientzehuang Pharmaceutical.,	118.85B
Aier Eye Hospital Group	114.24B
Shanghai United Imaging Healthcare	101.76B
Yunnan Baiyao Group Co.,Ltd	99.21B

Market Cap Rankings